Europe Microcarriers Market Forecast to 2030
Europe Microcarriers Market Forecast to 2030 – Regional Analysis – by Product (Media & Reagents and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes)
$2,840 – $4,440
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Strategic Initiatives and Innovative Products by Microcarrier Manufacturers Drive Europe Microcarriers Market
Companies operating in the microcarriers market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the microcarriers market are mentioned, In October 2023, Kuraray Co., Ltd. developed PVA hydrogel microcarriers for cell cultures used in regenerative medicine. The product is scheduled for launch in January 2024 in Japan and overseas, beginning in the US. In June 2023, Teijin Frontier introduced new nonwoven microcarriers that enable speedy, large-scale, high-quality cell culture. The new nonwoven microcarriers combine Teijin Frontier’s proprietary fiber process and nonwoven design technology, and fiber-related biomedical expertise by the Faculty of Engineering, University of Fukui, Japan. In October 2023, Semarion, unveiled the Early Adopter Programme for its SemaCyte Microcarrier Platform. SemaCytes developed by Semarion are cell carrier materials created using microchip fabrication technologies, nanomagnetism, and smart materials. These assaying microcarriers are flat and function as ultraminiaturized, magnetically steerable wells that carry small colonies of adherent cells into suspension to improve cell-based experiments. In January 2021, Thermo Fisher Scientific Inc acquired Henogen S.A., a Belgium-based viral vector manufacturing business of Groupe Novasep SAS. Henogen provides vaccine and therapeutics manufacturing services to biotechnology companies and large biopharmaceutical customers. With this acquisition, Thermo Fisher Scientific expanded its capabilities in the cell and gene vaccines and therapies category. In November 2020, researchers from the Singapore-MIT Alliance for Science and Technology (SMART) developed a novel microcarrier for large-scale cell production and cell expansion. Employing this microcarrier would allow businesses to have higher yields in a more cost-effective way than traditional methods while lowering the number of steps involved in the cell retrieval process. This newly developed dissolvable Gelatin microcarrier from SMART can be used in cell expansion for treating various ailments, including bone and cartilage defects, and graft vs. host disease, i.e., the rejection of foreign bone marrow and cells. Therefore, introducing products such as PVA hydrogel microcarriers, nonwoven microcarriers, and SemaCyte microcarrier platform, and the initiation of new businesses through collaborations and partnerships to remain competitive in the market would create significant growth opportunities in the microcarriers market.
Europe Microcarriers Market Overview
Europe holds a significant share of the global microcarrier market. The market growth in this region is attributed to the well-developed healthcare sector and infrastructure, and the significantly high healthcare spending in economies such as Germany, the UK, France, Romania, and Portugal. The increasing demand for advancements in cell culture equipment for better biopharmaceutical productivity and ongoing research with reliable outcomes are resulting in automated cell culture processes and systems. In addition, contract manufacturing and research facilities are operating on huge scales to meet the ever-increasing demands of the European healthcare sector for advanced treatment options. The pharmaceutical industry in Germany consists of small and mid-sized companies; it ranks fourth among the countries with the largest pharmaceutical industries in the world. As per the International Trade Administration (ITA), the pharmaceutical market in Germany accounted for ~US$ 62.5 billion in 2019. The country is most likely to remain one of the most desirable destinations for the global pharmaceutical industries over the coming years in terms of manufacturing and supply. The industry’s growth is driven by factors such as increasing investments in R&D and the elevating number of patent applications. The Federal Institute for Vaccines and Biomedical Products at Paul-Ehrlich-Institut (PEI) conducts the batch testing of influenza vaccines before their release into the German market. Germany has a strong pharmaceutical industry with a notable R&D focus. As per a NecstGen report, more than 29 active clinical trials evaluating CAR-modified immune cells were underway in Germany in 2021, and the majority of the production involved CAR-T cells. Also, over 50 clinical studies have been conducted in gene therapy in Germany so far.
Europe Microcarriers Market Revenue and Forecast to 2030 (US$ Million)
Europe Microcarriers Market Segmentation
The Europe microcarriers market is segmented into product, equipment, application, end user, and country.
Based on product, the Europe microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held a larger share of the Europe microcarriers market in 2022.
In terms of equipment, the Europe microcarriers market is segmented into bioreactors, culture vessels, and others. The bioreactors segment held the largest share of the Europe microcarriers market in 2022.
Based on application, the Europe microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production segment held the largest share of the Europe microcarriers market in 2022. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.
Based on end user, the Europe microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held the largest share of the Europe microcarriers market in 2022.
Based on country, the Europe microcarriers market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe microcarriers market in 2022.
Teijin Ltd, Bio-Rad Laboratories Inc, denovoMATRIX GmbH, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Percell Biolytica AB, Asahi Kasei Corp, and Polysciences Inc are some of the leading companies operating in the Europe microcarriers market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team research, the Europe microcarriers market was valued at US$ 417.19 million in 2022 and is expected to reach US$ 1,035.52 million by 2030, registering a CAGR of 12.0% from 2022 to 2030. Need for cell therapies with rising incidence of cancer and infectious diseases and surge in adoption of regenerative medicine are among the critical factors attributed to the Europe microcarriers market expansion.
The rising adoption of regenerative medicine has emerged as a significant driver propelling the growth of the microcarriers market. Regenerative medicine focuses on repairing, replacing, or regenerating damaged tissues and organs, making it a promising field for addressing various medical conditions. Microcarriers play a pivotal role in the cultivation and expansion of cells, a fundamental aspect of regenerative medicine. In regenerative medicine, cells are cultured outside the body before being transplanted, and microcarriers provide a suitable environment for cell attachment, proliferation, and differentiation. They serve as a substrate for cell growth in bioreactors, facilitating the efficient production of large quantities of cells. This is particularly crucial for regenerative therapies, where a substantial number of viable and functional cells are needed. Moreover, microcarriers enhance the scalability and cost-effectiveness of cell processes, addressing key challenges in the translation of regenerative medicine from research to clinical applications. As the regenerative medicine field continues to advance, with an increasing focus on stem cell therapies and tissue engineering, the demand for microcarriers is expected to escalate, driving innovation and expansion within the microcarriers market.
On the contrary, high cost of biologics and cell-based therapies hampers the Europe microcarriers market.
Based on product, the Europe microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held 67.2% share of Europe microcarriers market in 2022, amassing US$ 280.29 million. It is projected to garner US$ 708.79 million by 2030 to expand at 12.3% CAGR during 2022-2030.
In terms of equipment, the Europe microcarriers market is categorized into bioreactors, culture vessels, and others. The bioreactors segment held 65.6% share of Europe microcarriers market in 2022, amassing US$ 273.54 million. It is projected to garner US$ 692.29 million by 2030 to expand at 12.3% CAGR during 2022-2030.
Based on application, the Europe microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production beads segment held 51.0% share of Europe microcarriers market in 2022, amassing US$ 212.84 million. It is projected to garner US$ 549.07 million by 2030 to expand at 12.6% CAGR during 2022-2030. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.
Based on end user, the Europe microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held 55.9% share of Europe microcarriers market in 2022, amassing US$ 233.36 million. It is projected to garner US$ 593.06 million by 2030 to expand at 12.4% CAGR during 2022-2030.
By country, the Europe microcarriers market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 29.9% share of Europe microcarriers market in 2022. It was assessed at US$ 124.93 million in 2022 and is likely to hit US$ 323.34 million by 2030, exhibiting a CAGR of 12.6% during 2022-2030.
Key players operating in the Europe microcarriers market are Teijin Ltd, Bio-Rad Laboratories Inc, denovoMATRIX GmbH, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Percell Biolytica AB, Asahi Kasei Corp, and Polysciences Inc, among others.
In June 2023, Teijin Ltd introduced the new nonwoven microcarriers for speedy and large-scale cell culture. This scaffolding substance promotes three-dimensional adhesion and growth for a variety of cell types.
In May 2022, Saint-Gobain Life Sciences released beadMATRIX for mesenchymal stromal cells (MSCs). beadMATRIX are ready-to-use, pre-coated microcarriers free of animal components that are used to cultivate superior MSCs in vitro. Shaker bags, stirred tanks, vertical wheel bioreactors, and shaker flasks are the perfect environments for beadMATRIX.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Europe microcarriers market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Microcarriers Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
4.1.3 Surge in Adoption of Regenerative Medicine
4.2 Market Restraints
4.2.1 High Cost of Biologics and Cell-based Therapies
4.3 Market Opportunities
4.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
4.4 Future Trends
4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
4.5 Impact Analysis
5. Microcarriers Market – Europe Market Analysis
5.1 Microcarriers Market Revenue (US$ Mn), 2022 – 2030
6. Europe Microcarriers Market – Revenue and Forecast to 2030 – by Product
6.1 Overview
6.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Microcarrier Beads
6.3.1 Overview
6.3.2 Microcarrier Beads: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Media and Reagents
6.4.1 Overview
6.4.2 Media and Reagents: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
7. Europe Microcarriers Market – Revenue and Forecast to 2030 – by Equipment
7.1 Overview
7.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
7.3 Bioreactors
7.3.1 Overview
7.3.2 Bioreactors: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Culture Vessels
7.4.1 Overview
7.4.2 Culture Vessels: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Microcarriers Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Biopharmaceutical Production
8.3.1 Overview
8.3.2 Biopharmaceutical Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.3.3 Therapeutic Protein Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.3.4 Vaccine Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Cell and Gene Therapy
8.4.1 Overview
8.4.2 Cell and Gene Therapy: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Tissue Engineering and Regenerative Medicine
8.5.1 Overview
8.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Microcarriers Market Revenue and Forecasts To 2030 – End User
9.1 Overview
9.2 Europe Microcarriers Market Share by End User – 2022 & 2030 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Research Organizations and Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
10. Europe Microcarriers Market Revenue and Forecasts to 2030 – Country Analysis
10.1 Europe Microcarriers Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 Europe: Microcarriers Market, by Country
10.1.2.1 Germany
10.1.2.1.1 Overview
10.1.2.1.2 Germany: Microcarriers Market Revenue and Forecast to 2030 (GERMANY$ Mn)
10.1.2.1.3 Germany: Microcarriers Market, by Product
10.1.2.1.4 Germany: Microcarriers Market, by Equipment
10.1.2.1.5 Germany: Microcarriers Market, by Application
10.1.2.1.5.1 Germany: Microcarriers Market, by Biopharmaceutical Production
10.1.2.1.6 Germany: Microcarriers Market, by End User
10.1.2.2 UK
10.1.2.2.1 Overview
10.1.2.2.2 UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.3 UK: Microcarriers Market, by Product
10.1.2.2.4 UK: Microcarriers Market, by Equipment
10.1.2.2.5 UK: Microcarriers Market, by Application
10.1.2.2.5.1 UK: Microcarriers Market, by Biopharmaceutical Production
10.1.2.2.6 UK: Microcarriers Market, by End User
10.1.2.3 France
10.1.2.3.1 Overview
10.1.2.3.2 France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.3.3 France: Microcarriers Market, by Product
10.1.2.3.4 France: Microcarriers Market, by Equipment
10.1.2.3.5 France: Microcarriers Market, by Application
10.1.2.3.5.1 France: Microcarriers Market, by Biopharmaceutical Production
10.1.2.3.6 France: Microcarriers Market, by End User
10.1.2.4 Italy
10.1.2.4.1 Overview
10.1.2.4.2 Italy: Microcarriers Market Revenue and Forecast to 2030 (ITALY$ Mn)
10.1.2.4.3 Italy: Microcarriers Market, by Product
10.1.2.4.4 Italy: Microcarriers Market, by Equipment
10.1.2.4.5 Italy: Microcarriers Market, by Application
10.1.2.4.5.1 Italy: Microcarriers Market, by Biopharmaceutical Production
10.1.2.4.6 Italy: Microcarriers Market, by End User
10.1.2.5 Spain
10.1.2.5.1 Overview
10.1.2.5.2 Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.5.3 Spain: Microcarriers Market, by Product
10.1.2.5.4 Spain: Microcarriers Market, by Equipment
10.1.2.5.5 Spain: Microcarriers Market, by Application
10.1.2.5.5.1 Spain: Microcarriers Market, by Biopharmaceutical Production
10.1.2.5.6 Spain: Microcarriers Market, by End User
10.1.2.6 Rest of Europe
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.3 Rest of Europe: Microcarriers Market, by Product
10.1.2.6.4 Rest of Europe: Microcarriers Market, by Equipment
10.1.2.6.5 Rest of Europe: Microcarriers Market, by Application
10.1.2.6.5.1 Rest of Europe: Microcarriers Market, by Biopharmaceutical Production
10.1.2.6.6 Rest of Europe: Microcarriers Market, by End User
11. Microcarriers Market-Industry Landscape
11.1 Overview
11.2 Organic Growth Strategies
11.2.1 Overview
11.3 Inorganic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Teijin Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Bio-Rad Laboratories Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 denovoMATRIX GmbH
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sartorius AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Danaher Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Corning Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Eppendorf SE
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Percell Biolytica AB
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Asahi Kasei Corp
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Polysciences Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Research Team
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Microcarriers Market Segmentation
Table 2. Germany Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 3. Germany Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 4. Germany Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 5. Germany Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 6. Germany: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 7. UK Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 8. UK Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 9. UK Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 10. UK Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 11. UK: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 12. France Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 13. France Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 14. France Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 15. France Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 16. France: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 17. Italy Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 18. Italy Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 19. Italy Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 20. Italy Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 21. Italy: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 22. Spain Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 23. Spain Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 24. Spain Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 25. Spain Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 26. Spain: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 27. Rest of Europe Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 28. Rest of Europe Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 29. Rest of Europe Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 30. Rest of Europe Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 31. Rest of Europe: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 32. Recent Organic Growth Strategies in Microcarriers Market
Table 33. Recent Inorganic Growth Strategies in the Microcarriers Market
Table 34. Glossary of Terms
LIST OF FIGURES
Figure 1. Microcarriers Market Segmentation, By Country
Figure 2. Key Insights
Figure 3. Microcarriers Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints for Microcarriers Market
Figure 5. Microcarriers Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
Figure 7. Microcarrier Beads: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Media and Reagents: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 10. Bioreactors: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Culture Vessels: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
Figure 14. Biopharmaceutical Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Therapeutic Protein Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Vaccine Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cell and Gene Therapy: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Tissue Engineering and Regenerative Medicine: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Microcarriers Market Share by End User – 2022 & 2030 (%)
Figure 21. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 22. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 23. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 24. Microcarriers Market, 2022 (US$Mn)
Figure 25. Europe: Microcarriers Market, By Countries, 2022 And 2030 (%)
Figure 26. Germany: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Italy: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
The List of Companies – Europe Microcarriers Market
1. Teijin Ltd
2. Bio-Rad Laboratories Inc
3. denovoMATRIX GmbH
4. Sartorius AG
5. Danaher Corp
6. Corning Inc
7. Eppendorf SE
8. Percell Biolytica AB
9. Asahi Kasei Corp
10. Polysciences Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.